Trump secures drugmaker deals to cut Medicaid prices
President Donald Trump said Friday his administration reached agreements with nine additional major drugmakers — bringing 14 of the 17 largest firms on board — to a 'most‑favored‑nation' pricing initiative aimed at keeping Medicaid drug costs at or below prices in other high‑income countries. The deals also include a combined $150 billion in new U.S. investment commitments and contributions of active pharmaceutical ingredients to a federal reserve, with a new TrumpRX.gov site set to launch in January 2026.
📌 Key Facts
- New signatories include Amgen, Boehringer Ingelheim, Bristol‑Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi
- Total participating firms now 14 of the 17 largest global manufacturers, following earlier deals with Pfizer, AstraZeneca, Serrano, Novo Nordisk and Eli Lilly
- $150B in combined commitments for U.S. manufacturing and R&D; some firms will donate APIs to the Strategic Active Pharmaceutical Ingredients Reserve
📊 Relevant Data
The monthly list price of Ozempic is $936 in the United States, compared to $169 in Japan and $83 in France.
List prices for Ozempic, Wegovy far higher in the US than in peer nations: KFF — Fierce Healthcare
Black and Latino adults had the highest rates of obesity at 49.9 percent and 45.6 percent respectively in 2025.
State of Obesity Report 2025 : Better Policies for a Healthier America — Trust for America's Health
Obesity disproportionately affects individuals from low socioeconomic backgrounds as well as racial and ethnic minority populations.
Sociodemographic Disparities in Obesity Prevalence Among Adults in the United States, 2017-2020 — PMC (PubMed Central)
In 2025, Hispanic people comprised 30.8% of Medicaid enrollees versus 19.7% of the population, and Black people 20.8% of enrollees.
What the data says about Medicaid — Pew Research Center
Social determinants of health, such as where someone lives, and social inequities are primary drivers of obesity disparities.
Social and structural factors are key drivers of disparities in obesity rates — George Mason University Public Health
📰 Source Timeline (1)
Follow how coverage of this story developed over time